J.P. Morgan
236 articles with J.P. Morgan
-
The JP Morgan Health Care Conference is held annually in January, and usually kicks off the biggest biopharma business news stories of the year. But in 2022, it’ll do so without at least three big names in the industry.
-
The global biopharmaceutical company said that it is well capitalized with cash, cash equivalents, restricted cash, and investments of as much as $222.8 million as of 30 June 2021.
-
Molecular Partners announced yesterday it has filed for a $100 million initial public offering with the Securities and Exchange Commission in the U.S., funding which will go toward supporting the company's work in the development of protein-based treatments for COVID-19 and various cancers.
-
The Medicines Company Announces Launch of Public Offering of Common Stock
6/24/2019
The Company expects to use the net proceeds of the offering to fund its development of inclisiran and for general corporate purposes.
-
Ahead of the JP Morgan Healthcare Conference, Jamie Dimon, chief executive officer of JP Morgan Chase, hosted a private dinner for biopharma executives Sunday night. Although the dinner was private, apparently one of the hot topics of discussion was a company not represented at the party—Amazon.
-
Sangamo Therapeutics To Present at the 37th Annual J.P. Morgan Healthcare Conference
1/4/2019
Sangamo Therapeutics, Inc. announced that Sandy Macrae, CEO of Sangamo, will present a corporate overview at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, January 9th at 11:30 a.m. PT in San Francisco
-
Heska to Present at J.P. Morgan 2019 Healthcare Conference
1/4/2019
Heska Corporation announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the J.P. Morgan 2019 Healthcare Conference on Thursday, January 10, 2019 at 11 a.m. PT in San Francisco, CA.
-
Kenneth Frazier, chief executive officer of Merck, speaking with the Economic Club of New York, joined a growing list of pharmaceutical chiefs in criticizing the role of middlemen in rising drug prices.
-
Atul Gawande is heading out to hold one-on-one meetings with employees of a new healthcare venture to get a handle on their healthcare needs, challenges and concerns.
-
In January, Berkshire Hathaway, Amazon and JP Morgan Chase announced they were creating a joint healthcare venture. Today, they announced that Atul Gawande will be the chief executive officer.
-
Organizers said the media will be barred from the Q&A breakout sessions this year.
-
Biogen to Present at the 36th Annual J.P. Morgan Healthcare Conference
12/19/2017
To access the live webcast, please visit Biogen’s Investors section at www.biogen.com/investors.
-
Incyte to Present at Upcoming Investor Conference
12/14/2017
Incyte Corporation announced today that it will present at the 36th Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2018 at 1:30 pm (PST) in San Francisco.
-
JPM17: Why the Key to Gene Therapy Could be in an Old Bay Area Warehouse
1/16/2017
-
JPM17: Surprise! Pfizer is Still Deal Hungry for M&As After Medivation
1/16/2017
-
JPM17: Opko Health CEO's Gameplan After Its Recent Growth Hormone Failure
1/13/2017
-
JPM17: New Biogen CEO on Groundbreaking Alzheimer's Trial and the Company's Future
1/12/2017
-
JPM17: Kite Pharma's Strategy for Commercializing Its Lead CAR-T Drug
1/12/2017
-
JPM17: For Medtronic, Old Data Habits Die Hard
1/12/2017
-
JPM17: CureVac Release: Biotech's mRNA Program Fails Phase II Test, Putting Spotlight on Other Biotechs Like Moderna
1/12/2017